US Cancer Biomarkers Market will experience a noticeable growth during the forecast period 2019-2025

US cancer biomarker market is anticipated to grow at a CAGR of 11.8% during the forecast period. The US cancer biomarker market in the North American region is dominating due to various factors such as investments in research and development, high healthcare expenditure, presence of key players and rising prevalence of cancer patients.

Request a Free Sample of our Report on US Cancer Biomarkers Market: https://www.omrglobal.com/request-sample/us-cancer-biomarker-market

The proactiveness of prostate cancer research organizations in the US are contributing to the market growth. Many organizations fund researchers for supporting their study for cancer research and bringing innovative treatments to the market. There are many organizations working in the US that are creating awareness regarding prostate cancer in men.

US Too-International, Prostate Cancer Education and Support network and the Prostate cancer research organization are some of the organizations in the category. There are special organizations as well in the US, for instance, Malecare is a cancer support organization offering help and assistance to gay people with prostate cancer and other cancers. These organizations are increasing public knowledge for prostate cancer and educating them regarding the treatments available in the country. Hence, contributing to the US cancer biomarker market.

According to the American Cancer Society in 2017, it was estimated that out of total 600,920 cancer deaths in the US, around 190,500 would be caused by cigarette smoking. In addition, it was estimated by the World Cancer Research Fund that 20% of cancers are caused by f factors such as physical inactivity, excess body weight, excess alcohol consumption and poor nutrition. Cancer is usually developed among older people.

According to the American Cancer Society in 2017, 87% of all the cancers in the US were diagnosed in people with age 50 years and above. These cancers are preventable. Moreover, colorectal and cervical cancers can be prevented by screening and by removal of precancerous lesions. Screening also have reduced the mortality rate significantly for the cancers of colon, breast, and lung.

A Full Report of US Cancer Biomarkers Market is Available at https://www.omrglobal.com/industry-reports/us-cancer-biomarker-market

US Cancer Biomarkers Cancer Biomarker Market Segmentation

By Biomarker Type
o Genetic Biomarker
o Protein Biomarker

By Cancer Type
o Lung Cancer
o Prostate Cancer
o Breast Cancer
o Colorectal Cancer
o Cervical Cancer
o Other

By Applications
o Drug Discovery and Development
o Diagnosis
o Risk Assessment
o Prognostics

By Profiling Technology
o Omics Technology
o Immunoassays
o Cytogenetics
o Bioinformatics

Company Profiles
o Abbott laboratories Inc.
o Astellas Pharma Inc.
o Becton, Dickson and Co.
o Bio-Rad Laboratories, Inc.
o Danaher Corp.
o F. Hoffmann-La Roche Ltd.
o Merck and Co., Inc.
o Novartis AG
o Pfizer Inc.
o QIAGEN GmbH
o Thermo Fisher Scientific Inc.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/us-cancer-biomarker-market

For More Information, Visit https://www.omrglobal.com/

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +1 646-755-7667, +91 780-304-0404

About us:

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.